Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Open-Label Trial of CONvalenscent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (CONCOR-1)

NCT04348656 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT04348656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Open-Label Trial of CONvalenscent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (CONCOR-1)
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 3
Overall status
Terminated
Start date
March 14, 2020
Completion date
June 16, 2021
Enrollment
940 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19